查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008353

經經皮腎鏡取石術市場：依產品類型、手術類型、結石類型、入路、病患類型、應用和最終用戶分類－2026-2032年全球市場預測

Percutaneous Nephrolithotomy Market by Product Type, Procedure Type, Stone Type, Access Approach, Patient Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，經皮腎鏡取石術市場價值為 8.1377 億美元，到 2026 年成長至 8.783 億美元，到 2032 年達到 14.2829 億美元，年複合成長率為 8.36%。

主要市場統計數據
基準年 2025 8.1377億美元
預計年份：2026年 8.783億美元
預測年份 2032 1,428,290,000 美元
複合年成長率 (%) 8.36%

一個清晰的臨床和商業性框架，將不斷發展的外科手術實踐、醫療設備創新和經皮腎鏡取石術。

經皮腎鏡取石術)仍然是體外震波碎石術 (ESW) 或純內視鏡治療無法處理的臨床顯著腎結石的基石治療方法。臨床醫生、醫院管理者和醫療設備製造商正努力應對這樣一個環境：手術方案的選擇受到病患合併症、結石複雜程度以及器械和影像技術進步的影響。在實踐中，這意味著入路系統、腎鏡、碎石平台以及輔助引流和閉塞裝置必須整合到醫療機構的工作流程中，同時滿足日益嚴格的安全性和效率要求。在整個醫療過程中，人們強烈希望最大限度地減少輻射暴露、減少泌尿道出血，並在不移除結石或損害長期腎功能的前提下縮短住院時間。這些臨床需求，加上對一次性醫療設備日益成長的需求、門診服務的擴展以及數位導航技術的普及，正在重塑所有相關人員的採購、培訓和夥伴關係策略。

小型化、影像技術和機器人輔助導航的結合正在迅速改變腎結石治療的設備設計、臨床實踐和機構工作流程。

經經皮腎鏡取石術領域正經歷一場融合式變革，涵蓋器械小型化、手術流程最佳化、數位導航以及治療部位的轉變。從微型、超微型、微型到改良的標準方法，各種小型化通路策略均得到共識指南和隨機對照試驗數據的支持，這些數據表明，這些策略在降低出血併發症和輸血風險的同時，還能在多種結石負荷下保持相當的結石清除率。這些臨床數據推動了對更小尺寸腎鏡、專用擴張器和細鞘套以及針對低位入路最佳化的取石平台的需求。同時，影像和導航技術正透過超音波引導、擴增實境（AR）規劃和機器人輔助針頭引導系統，減少對透視的依賴。早期可行性研究和臨床病例係列研究表明，這些技術可以提高首次穿刺成功率，並減少患者和醫務人員的輻射暴露。雖然機器人輔助和導航系統尚未普及，但在專注於高頻複雜碎石治療計畫和學術培訓計畫的機構中，其應用正在不斷增加，這加速了功能和特性方面的競爭，並改變了製造商優先考慮整合和支援外科醫生的方式。

美洲、歐洲、中東和非洲以及亞太地區的區域差異正在決定採購重點、監管途徑和部署速度。

區域趨勢對監管路徑、採購偏好和臨床工作流程有顯著影響，而這些對於產品設計和商業策略至關重要。在美洲，醫院整合、大規模綜合醫生集團以及完善的門診手術中心生態系統正在形成高流量區域，標準化耗材包和可預測的服務合約能夠在這些區域獲得市場佔有率。支付結構和合約實務強調能夠提高處理能力、縮短住院時間並與現有無菌或一次性使用策略整合的醫療設備。歐洲、中東和非洲 (EMEA) 地區是一個多元化的市場，其影響因素包括各國特定的採購結構、對衛生技術評估 (HTA) 的更高重視程度以及國內生產能力的差異。因此，供應商必須調整監管文件、本地服務結構和性價比策略才能成功。在許多 EMEA 市場，感染控制和採購透明度是推動一次性產品普及的重要因素，而環境和循環經濟的考量也日益影響競標評估。亞太地區在三級醫療機構中迅速採用先進的影像和導航技術，擁有強大的原始設備製造商 (OEM) 和零件供應基礎，以及多樣化的報銷模式。確保這些技術在這些市場的永續應用通常需要與當地契約製造建立合作關係，並建立有針對性的臨床證據。了解這些區域差異（例如人員技能、細緻的報銷方案和當地供應商生態系統）對實際應用的影響，有助於企業制定差異化的監管應對措施、臨床證據和商業性投資方案，以適應當地的優先事項和風險接受度。當臨床證據和模組化平台與穩健的供應鏈和服務主導的部署策略結合時，企業便能獲得競爭優勢。

領導者應優先採取實際有效的措施，使產品藍圖、供應鏈和服務模式與不斷變化的臨床和商業性需求保持一致。

產業領導者應在多個領域採取果斷行動，以確保先進經皮腎鏡取石術技術的普及應用、維持獲利能力並加速永續推廣。首先，他們應使產品藍圖與臨床對更小巧、更安全入路的需求保持一致。應優先開發低輪廓腎鏡、通道系統和灌注/抽吸解決方案，以在保持療效的同時減少組織損傷。其次，他們應投資於成像和導航的互通性，使系統能夠與現有的透視、超音波設備和新興的3D規劃生態系統連接。開放的介面和臨床整合將減少採購摩擦並縮短部署時間。第三，他們應重新考慮全球採購和組裝地點，以降低關稅風險和零件短缺的影響。在更靠近市場的組裝、關鍵光學和半導體組件的雙重採購以及透明的供應商可追溯性對於縮短前置作業時間和維持盈利能力至關重要。第四，我們將建立一個服務包，結合外科培訓、遠距教學和耗材定價模式，專為高吞吐量的門診環境而設計，在這些環境中，可預測的病例成本至關重要。最後，我們將把環境因素納入一次性產品策略，試行推行回收和產品召回計劃，並向採購委員會透明地傳達產品生命週期影響。解決這些優先事項不僅可以緩解貿易政策變化帶來的短期不利影響，還能為各機構在治療模式和醫療場所選擇不斷變化的情況下獲得永續的競爭優勢奠定基礎。

透明的調查方法，說明了臨床證據的整合、貿易政策審查、與主要相關人員的訪談以及交叉檢驗的技術和商業性實質審查。

本分析所依據的研究整合了同儕審查的臨床文獻、對政策和監管公告的系統性回顧、對採購和臨床負責人的訪談，以及對產品系列和供應鏈的技術實質審查。臨床證據的整合利用了系統綜述、共識聲明和前瞻性可行性研究，以描述微型經皮腎鏡取石術（PCNL）技術和影像引導入路系統的安全性、相對療效和應用障礙。透過仔細審查政府公告和主要貿易機構的最新報告，評估了貿易和政策的影響，以了解關稅設計、豁免以及對醫療設備供應鏈的潛在營運影響。市場和企業分析結合了公開文件、監管核准記錄以及對選定的醫療設備製造商和高運作機構的直接訪談，以評估產品定位、服​​務模式和商業策略。在可能的情況下，交叉引用多個資料來源以檢驗關鍵結論，並透過與臨床醫生和供應鏈負責人的訪談來檢驗研究結果，以確保其與實際決策的相關性和準確性。

我們將臨床發展動能、關稅導致的採購趨勢變化以及策略需求連結起來，並將它們整合到一個連貫的相關人員。

總而言之，經經皮腎鏡取石術的實踐和商業性基礎正在經歷變革時期。臨床上，人們越來越傾向於採用較小的入路和影像引導技術，這推動了對專用低輪廓器械、高清成像和可互通導航的需求。同時，機器人技術和基於擴增實境（AR）的規劃工具正在重塑入路品質和培訓的模式。此外，2025年的關稅措施也凸顯了供應鏈策略、雙源採購和市場鄰近組裝的重要性，這些措施對於保護利潤率和確保關鍵零件的供應至關重要。終端使用者越來越關注能夠減少病例間差異、支持當日治療路徑並最大限度減少術後併發症的醫療設備和服務模式。對於製造商和醫療服務體係而言，成功需要協調投資於商業性創新性的服務產品，這些產品必須符合臨床證據、強大的製造能力以及現代醫療服務中對手術經濟性和環境影響的預期。以上具體建議可作為領導者的藍圖，幫助他們將這些見解轉化為合理的短期選擇，從而維持病患就醫途徑並支持組織績效。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：經皮腎鏡取石術市場：依產品類型分類

  • 訪問系統
    • 針
    • 導管導引線
    • 擴充器
    • 鞘套
  • 破碎機
    • 超音波碎石機
    • 氣動破碎機
  • 引流及閉塞裝置
    • 輸尿管支架
    • 腎造瘻管
    • 閉合裝置
  • 腎鏡
    • 軟性腎鏡
    • 硬式腎鏡
    • 數位腎鏡
  • 醫學影像和導航系統
    • X光系統
    • 3D導航機器人系統
    • 超音波引導系統
  • 一次性產品和配件
    • 吸力裝置
    • 清潔系統
    • 收集籃

第9章經皮腎鏡取石術術市場（依手術類型分類）

  • 微
  • 小型的
  • 標準
  • 超迷你

第10章：經皮腎鏡取石術市場（依結石類型分類）

  • 草酸鈣結石
  • 尿酸結石
  • 鳥糞石
  • 胱氨酸結石

第11章經皮腎鏡取石術市場進入方法

  • 俯臥進階
  • 仰臥位
  • 側臥入路

第12章 依病患類型分類的經皮腎鏡取石術市場

  • 成人版
  • 老年人
  • 兒童

第13章：經皮腎鏡取石術市場：依應用領域分類

  • 腎結石
  • 鹿角石

第14章：經皮腎鏡取石術市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 泌尿系統診所
  • 學術和研究機構

第15章：經皮腎鏡取石術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章：經皮腎鏡取石術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章經皮腎鏡取石術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國經皮腎鏡取石術市場

第19章：中國經皮腎鏡取石術市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advin Urology
  • Allengers Medical Systems Ltd.
  • Biorad Medisys Pvt Ltd.
  • Blue Neem Medical Devices Private Limited
  • Boen Healthcare Co., Ltd.
  • Boston Scientific Corporation
  • Coloplast Corporation
  • Cook Group Incorporated
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • ELMED INC.
  • Envaste Limited
  • Fore River Urology.
  • Manish Medi Innovation
  • Medispec Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Rocamed
  • Teleflex Incorporated
Product Code: MRR-C002B1C99560

The Percutaneous Nephrolithotomy Market was valued at USD 813.77 million in 2025 and is projected to grow to USD 878.30 million in 2026, with a CAGR of 8.36%, reaching USD 1,428.29 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 813.77 million
Estimated Year [2026] USD 878.30 million
Forecast Year [2032] USD 1,428.29 million
CAGR (%) 8.36%

A clear clinical and commercial framing that links evolving procedural practice, device innovation, and healthcare delivery priorities for percutaneous nephrolithotomy

Percutaneous nephrolithotomy remains a cornerstone intervention for clinically significant renal calculi that are not amenable to shockwave or purely endoscopic therapy. Clinicians, hospital administrators, and device manufacturers are navigating an environment where procedural choices are shaped by patient comorbidity, stone complexity, and the evolving technical capabilities of instruments and imaging. In practice, this means that access systems, nephroscopes, lithotripsy platforms, and adjunctive drainage and closure devices must integrate with facility workflows while meeting increasingly strict safety and efficiency expectations. Across the care continuum, there is strong emphasis on minimizing radiation exposure, reducing tract-related bleeding, and shortening length of stay without compromising stone clearance or long-term renal function. These clinical imperatives, together with rising demand for single-use disposables, expanded outpatient capabilities, and digitally enabled navigation, are reshaping procurement, training, and partnership strategies for all stakeholders.

Framing the market through this clinical lens highlights several immediate priorities: supporting surgeon training in miniaturized and image-guided techniques, ensuring supply chain robustness for critical consumables and components, and aligning product development with facility-level goals for throughput and value-based reimbursement. The following summary synthesizes the transformative shifts now underway, the specific implications of recent United States tariff actions in 2025, segmentation-level insights that inform product and go-to-market choices, regional differentiation, and pragmatic recommendations leaders can use to protect margins, preserve access, and accelerate responsible innovation.

Converging forces of miniaturization, imaging and robot-assisted navigation are rapidly reshaping device design, clinical practice, and facility workflows for kidney stone interventions

The landscape for percutaneous nephrolithotomy is undergoing convergent transformations that span device miniaturization, procedural technique, digital navigation, and care-site migration. Miniaturized tract strategies-spanning micro, ultra-mini, mini and modified standard approaches-have been supported by consensus guidance and randomized data demonstrating comparable stone-free outcomes for many stone burdens while reducing hemorrhagic complications and transfusion risk. These clinical data have in turn catalyzed demand for smaller nephroscopes, specialized dilators and thin sheaths, and lithotripter platforms optimized for low-profile access. Concurrently, imaging and navigation technologies are reducing dependence on fluoroscopy through ultrasound guidance, augmented reality planning, and robot-assisted needle targeting systems; early feasibility and clinical series show these technologies can improve first-pass access rates and reduce radiation exposure for patients and staff. Robotic and navigated systems are not yet ubiquitous, but they are increasingly adopted at centers focused on high-volume complex stone programs and academic training pathways, accelerating a competence-and-capability arms race that changes how manufacturers prioritize integration and surgeon support.

On the disposables front, single-use endoscopes, digital nephroscopes and disposable accessory portfolios are now a major strategic axis. These devices address infection control, reduce repair-related downtime, and simplify inventory management for high-throughput units, even as purchasers weigh environmental impact and unit economics. Finally, delivery-site migration toward higher-acuity ambulatory surgical centers and same-day care models is pressuring device makers to re-think portability, footprint, and service bundles so instruments can enable rapid turnover and predictable perioperative pathways. When taken together, these trends create a market that rewards modular platforms, interoperable imaging solutions, and manufacturer services that reduce the total cost and complexity of adoption while enabling rapid clinician learning curves and predictable patient outcomes. Evidence supporting miniaturization and image-guided techniques is consolidated in contemporary consensus statements and systematic reviews that are driving purchasing committees and clinical leaders to reassess legacy equipment portfolios and training investments; this is changing the timelines and priorities for product roadmaps across the ecosystem. How the 2025 United States tariff actions are creating immediate procurement pressure, supply chain reconfiguration, and strategic re-shoring incentives across device value chains

The tariff environment instituted in 2025 has introduced a new layer of commercial complexity for medical device sourcing, cost structures, and supplier selection. Official actions and policy modifications by trade authorities have translated into increased duties on a broad set of imported goods, and targeted adjustments to rates for specific product categories have been signaled through government releases and subsequent reporting. For suppliers that rely on cross-border manufacturing of precision components, optics, imaging subsystems, and semiconductor-containing controls, these duties materially raise landed costs and can lengthen procurement lead times while prompting immediate reassessments of near-term pricing and supplier contracts. In response, many health systems and physician groups face the choice of absorbing higher consumable prices, prioritizing domestic-sourced lines where available, or passing incremental cost through to purchasers where contracting levers allow.

Beyond direct price pressure, tariffs also accelerate strategic behaviors that change the competitive landscape. Manufacturers dependent on global contract manufacturing and just-in-time component supply face margin compression and potential product reengineering choices to substitute tariff-exposed components. Regulatory-driven exemptions and sector carve-outs have been applied in some instances, but the overall policy trajectory has incentivized re-shoring of critical production steps, diversification of supplier networks, and near-market final assembly for key imaging and navigation modules. Observers in the trade and healthcare sectors have documented the practical effects on both equipment categories and IT-dependent subsystems, noting acute sensitivity where semiconductor and high-precision electronics are integral to lithotripsy consoles, imaging suites and robotic controllers. Official trade documents and investigative reporting confirm that these policy changes are active and consequential for capital equipment and consumable procurement in 2025, prompting procurement teams to refresh total-cost-of-ownership models and contingency sourcing plans. A segmentation-led synthesis that links product architecture, procedural approach, patient phenotype, and end-user setting to commercial and clinical decision levers

Examining the market through carefully defined segmentation clarifies where clinical needs, procurement priorities, and technology opportunities intersect. When product type is used as the organizing principle, access systems-comprised of needles, guidewires, dilators, and sheaths-remain the procedural foundation because reliable, low-trauma access determines safety and the ability to complete stone clearance in a single session. Lithotripters split into ultrasonic and pneumatic approaches, each carrying different capital and consumable trade-offs and therefore appealing to different procedural mixes and facility economics. Drainage and closure devices, an essential adjunct to percutaneous practice, encompass ureteral stents, nephrostomy tubes, and sealing devices that influence recovery pathways and post-procedural morbidity. Nephroscopes now span flexible, rigid, and digital platforms with variable roles across micro, mini, and standard tract approaches, while imaging and navigation systems cover fluoroscopy, ultrasound-guided systems, and emerging 3D navigation and robotic-assist modalities that shape access quality. Disposables and accessories including suction devices, irrigation systems, and retrieval baskets form a high-turnover consumable layer that drives recurring revenue and inventory optimization concerns for providers.

Viewed by procedure type, micro, mini, standard and ultra-mini approaches each map onto different instrument sets and perioperative protocols; ultra-mini techniques require specialized low-profile optics and very fine sheaths, whereas standard procedures continue to rely on more robust channels and high-capacity lithotripsy. Stone type-such as calcium oxalate, uric acid, struvite, and cystine stones-determines fragmentation strategy and device wear characteristics, influencing consumable choice and energy delivery preferences. Access approach, whether prone, supine or lateral, influences OR setup, imaging orientation, and device ergonomics, and so product designers must appreciate working angles and sheath handling across patient positioning. Patient type-adult, geriatric and pediatric-requires differentiated sizing, anesthesia planning and post-operative pathway design, and application distinctions such as renal calculi versus complex staghorn calculi drive the need for multi-tract planning, combined techniques, or staged approaches. Finally, end users-ambulatory surgical centers, hospitals, specialty urology clinics and academic and research institutes-each exhibit distinct purchasing thresholds, service expectations, and training capacities that should inform go-to-market segmentation and support models. Integrating these segmentation lenses helps manufacturers prioritize modularity, inventoried consumables, and clinician education investments to maximize procedural fit and shorten time-to-adoption.

Regional differentiation across Americas, Europe Middle East & Africa, and Asia-Pacific determines procurement priorities, regulatory pathways, and adoption pacing

Regional dynamics exert distinct influences on regulatory pathways, procurement preferences and clinical workflows that matter for product design and commercial strategy. In the Americas, hospital consolidation, large integrated physician groups, and a robust ambulatory surgical center ecosystem create high-volume nodes where standardized consumable bundles and predictable service contracts can win share. Payment structures and contracting practices place a premium on devices that enable throughput, reduce length of stay and integrate with existing sterilization or single-use strategies. Europe, the Middle East and Africa present a heterogeneous mix where country-level procurement, stronger emphasis on health-technology assessment, and variable access to domestic manufacturing capacity mean that suppliers must adapt regulatory dossiers, local service footprints, and price-performance narratives to succeed. In many EMEA markets, infection control and procurement transparency are strong drivers of disposable adoption decisions, but environmental and circularity considerations increasingly influence tender evaluations. Asia-Pacific shows rapid adoption of advanced imaging and navigation in tertiary centers, an active OEM and component supply base, and a diverse set of reimbursement models; partnerships with regional contract manufacturers and targeted clinical evidence generation are often prerequisites for sustainable access across these markets. Understanding the practical implications of these regional differences-workforce skills, reimbursement nuance, and the local supplier ecosystem-enables companies to deploy differentiated regulatory, clinical evidence and commercial investments that fit local priorities and risk tolerances. Competitive advantage accrues to firms that pair clinical evidence and modular platforms with resilient supply chains and service-led adoption strategies

Company strategy in this space increasingly depends on the ability to combine clinical credibility, integrated service models, and modular technology platforms. Established manufacturers that supply access systems, lithotripters and imaging suites are balancing investment in next-generation, low-profile endoscopes and digital visualization with dealer and service channel optimization to protect installed base revenue. New entrants and smaller innovators are focusing on niche wins-novel sheath designs, low-cost ultrasound-guided access devices, disposable scope optics and software-enabled navigation-where rapid clinical evidence generation can create a pathway to inclusion in high-volume centers. Across both groups, partnerships with academic centers for human factors validation, multi-center registries, and real-world outcomes capture have become decisive differentiators at the tender and contract negotiation phases. Supply chain resilience, particularly for high-precision electronics and semiconductor-dependent subsystems, has emerged as a core competitive advantage; firms that can demonstrate multi-country sourcing and near-market assembly are better positioned to absorb tariff shocks and maintain supply continuity.

Service and support models are also evolving: companies that bundle training, simulation, and remote proctoring reduce the upfront friction associated with advanced navigation platforms and miniaturized techniques. Similarly, firms that co-design consumable pricing with high-use facilities to align per-case economics, introduce take-back or recycling programs for single-use devices, and offer flexible financing for capital equipment create compelling value propositions for procurement committees balancing cost, sustainability and clinical outcomes. These strategic choices-platform integration, evidence generation, supply chain transparency, and creative service models-will determine which companies move from vendor status to strategic partner in the emerging care pathways for kidney stone management.

Practical, high-impact actions leaders must prioritize to align product roadmaps, supply chains, and service models with evolving clinical and commercial demands

Industry leaders should act decisively on several fronts to preserve access, protect margins and accelerate sustainable adoption of advanced percutaneous nephrolithotomy technologies. First, align product roadmaps to the clinical imperative for smaller, safer access: prioritize development of lower-profile nephroscopes, tract systems and irrigation/suction solutions that reduce tissue trauma while maintaining efficacy. Second, invest in imaging and navigation interoperability so systems can plug into existing fluoroscopy, ultrasound and emerging 3D planning ecosystems; open interfaces and clinical integration reduce procurement friction and shorten onboarding timelines. Third, re-evaluate global sourcing and assembly footprints to mitigate tariff exposure and component scarcity; near-market assembly, dual-sourcing of key optics and semiconductor elements, and transparent supplier traceability will be essential to keep lead times short and margins intact. Fourth, construct service bundles that combine surgeon training, remote proctoring, and consumable pricing models designed for high-throughput ambulatory environments where predictable case cost matters most. Finally, incorporate environmental stewardship into disposable product strategies by piloting recycling or product take-back programs and communicating life-cycle impacts transparently to purchasing committees. Acting on these priorities will not only blunt short-term headwinds created by trade policy shifts, but will also position organizations to capture durable advantage as treatment patterns and care-site choices evolve.

Transparent methodology describing clinical evidence synthesis, trade-policy review, primary stakeholder interviews, and cross-validated technical and commercial diligence

The research underpinning this analysis integrates structured review of peer-reviewed clinical literature, policy and regulatory announcements, primary interviews with procurement and clinical leaders, and technical diligence on product portfolios and supply chains. Clinical evidence synthesis drew on systematic reviews, consensus statements and prospective feasibility studies to characterize procedural safety, comparative efficacy and adoption barriers across miniaturized PCNL techniques and image-guided access systems. Trade and policy impacts were assessed by reviewing government releases and contemporaneous reporting from primary trade authorities to understand tariff design, exemptions and likely operational impacts on medical device supply chains. Market and company analysis combined public filings, regulatory clearance records and primary outreach to selected device manufacturers and high-volume centers to evaluate product positioning, service models, and commercial tactics. Where possible, triangulation across multiple data sources was used to validate key assertions, and findings were stress-tested in interviews with clinicians and supply chain leaders to ensure practical relevance and fidelity to real-world decision-making.

Concluding synthesis that ties clinical momentum, tariff-induced procurement shifts, and strategic imperatives into a coherent action framework for stakeholders

In summary, the practice and commercial underpinnings of percutaneous nephrolithotomy are in transition. Clinical momentum toward miniaturized tracts and image-guided access is catalyzing demand for specialized low-profile instruments, high-fidelity imaging and interoperable navigation, while robotics and augmented planning tools are beginning to re-shape access quality and training paradigms. At the same time, the tariff actions in 2025 have heightened the importance of supply chain strategy, dual-sourcing, and near-market assembly as levers to protect margin and ensure availability of critical components. End users are increasingly focused on devices and service models that lower per-case variability, support same-day care pathways, and reduce downstream complications. For manufacturers and provider systems alike, success will require coordinated investment in clinical evidence, resilient manufacturing footprints, and commercially creative service offerings that align with the procedural economics and environmental expectations of modern healthcare delivery. The practical recommendations described above provide a roadmap for leaders to translate these insights into defensible, near-term choices that sustain patient access and institutional performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Nephrolithotomy Market, by Product Type

  • 8.1. Access Systems
    • 8.1.1. Needles
    • 8.1.2. Guidewires
    • 8.1.3. Dilators
    • 8.1.4. Sheaths
  • 8.2. Lithotripters
    • 8.2.1. Ultrasonic Lithotripters
    • 8.2.2. Pneumatic Lithotripters
  • 8.3. Drainage & Closure Devices
    • 8.3.1. Ureteral Stents
    • 8.3.2. Nephrostomy Tubes
    • 8.3.3. Sealing Devices
  • 8.4. Nephroscopes
    • 8.4.1. Flexible Nephroscopes
    • 8.4.2. Rigid Nephroscopes
    • 8.4.3. Digital Nephroscopes
  • 8.5. Imaging & Navigation Systems
    • 8.5.1. Fluoroscopy Systems
    • 8.5.2. 3D Navigation & Robotic Systems
    • 8.5.3. Ultrasound-Guided Systems
  • 8.6. Disposables & Accessories
    • 8.6.1. Suction Devices
    • 8.6.2. Irrigation Systems
    • 8.6.3. Retrieval Baskets

9. Percutaneous Nephrolithotomy Market, by Procedure Type

  • 9.1. Micro
  • 9.2. Mini
  • 9.3. Standard
  • 9.4. Ultra Mini

10. Percutaneous Nephrolithotomy Market, by Stone Type

  • 10.1. Calcium Oxalate Stones
  • 10.2. Uric Acid Stones
  • 10.3. Struvite Stones
  • 10.4. Cystine Stones

11. Percutaneous Nephrolithotomy Market, by Access Approach

  • 11.1. Prone Access
  • 11.2. Supine Access
  • 11.3. Lateral Access

12. Percutaneous Nephrolithotomy Market, by Patient Type

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Percutaneous Nephrolithotomy Market, by Application

  • 13.1. Renal Calculi
  • 13.2. Staghorn Calculi

14. Percutaneous Nephrolithotomy Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals
  • 14.3. Specialty Urology Clinics
  • 14.4. Academic & Research Institutes

15. Percutaneous Nephrolithotomy Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Percutaneous Nephrolithotomy Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Percutaneous Nephrolithotomy Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Percutaneous Nephrolithotomy Market

19. China Percutaneous Nephrolithotomy Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Advin Urology
  • 20.6. Allengers Medical Systems Ltd.
  • 20.7. Biorad Medisys Pvt Ltd.
  • 20.8. Blue Neem Medical Devices Private Limited
  • 20.9. Boen Healthcare Co., Ltd.
  • 20.10. Boston Scientific Corporation
  • 20.11. Coloplast Corporation
  • 20.12. Cook Group Incorporated
  • 20.13. Dornier MedTech
  • 20.14. E.M.S. Electro Medical Systems S.A.
  • 20.15. EDAP TMS SA
  • 20.16. ELMED INC.
  • 20.17. Envaste Limited
  • 20.18. Fore River Urology.
  • 20.19. Manish Medi Innovation
  • 20.20. Medispec Ltd.
  • 20.21. Olympus Corporation
  • 20.22. Richard Wolf GmbH
  • 20.23. Rocamed
  • 20.24. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC LITHOTRIPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC LITHOTRIPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC LITHOTRIPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC LITHOTRIPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC LITHOTRIPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC LITHOTRIPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSTOMY TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSTOMY TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSTOMY TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SEALING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SEALING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SEALING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLEXIBLE NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLEXIBLE NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLEXIBLE NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RIGID NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RIGID NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RIGID NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DIGITAL NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DIGITAL NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DIGITAL NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLUOROSCOPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLUOROSCOPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FLUOROSCOPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY 3D NAVIGATION & ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY 3D NAVIGATION & ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY 3D NAVIGATION & ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASOUND-GUIDED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASOUND-GUIDED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASOUND-GUIDED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUCTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUCTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IRRIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IRRIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IRRIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RETRIEVAL BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RETRIEVAL BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RETRIEVAL BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CALCIUM OXALATE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CALCIUM OXALATE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CALCIUM OXALATE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URIC ACID STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URIC ACID STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY URIC ACID STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STRUVITE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STRUVITE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STRUVITE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CYSTINE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CYSTINE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CYSTINE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRONE ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRONE ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRONE ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUPINE ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUPINE ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUPINE ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LATERAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LATERAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LATERAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SPECIALTY UROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SPECIALTY UROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SPECIALTY UROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 278. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 281. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 282. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DISPOSABLES & ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 283. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS APPROACH, 2018-2032 (USD MILLION)
  • TABLE 286. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DRAINAGE & CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY IMAGING & NAVIGATION SYSTEMS,